Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-14

FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for ALISKIREN Hemifumarate (Prasco Laboratories).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren Hemifumarate (Aliskiren hemifumarate)

Snippet

SUPPL AP for ALISKIREN (ALISKIREN HEMIFUMARATE)